- Report
- November 2024
- 120 Pages
Global
From €5318EUR$5,950USD£4,545GBP
- Report
- October 2023
- 75 Pages
Global
From €5318EUR$5,950USD£4,545GBP
- Report
- August 2025
- 184 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 192 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 198 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 189 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 189 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- August 2025
- 192 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- April 2025
Global
From €4379EUR$4,900USD£3,743GBP
- Report
- December 2023
- 109 Pages
Global
From €3575EUR$4,000USD£3,055GBP
- Report
- January 2024
- 200 Pages
Global
From €3709EUR$4,150USD£3,170GBP
- Report
- March 2024
- 118 Pages
Global
From €4022EUR$4,500USD£3,437GBP
- Report
- August 2025
- 188 Pages
Global
From €3168EUR$3,545USD£2,708GBP
€3520EUR$3,939USD£3,009GBP
- Report
- October 2023
- 78 Pages
United States
From €3128EUR$3,500USD£2,673GBP
- Report
- December 2024
- 85 Pages
India
From €3128EUR$3,500USD£2,673GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1341EUR$1,500USD£1,146GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1787EUR$2,000USD£1,528GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£955GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1117EUR$1,250USD£955GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1787EUR$2,000USD£1,528GBP
![Loading Indicator](/images/loading.gif")
The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more
![º¬Ðß²ÝÊÓƵ](/images/logo.svg"){kind=logo}
![º¬Ðß²ÝÊÓƵ](/images/logo-research-and-markets-print.png"){kind=logo}